We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

New Comprehensive Blood Safety Portfolio Launched at Arab Health 2014

By LabMedica International staff writers
Posted on 04 Feb 2014
Print article
Image: Roche’s Cobas modular analyzer for the "Roche Blood Safety Solution" launched at Arab Health 2014 (Photo courtesy of Roche Diagnostics).
Image: Roche’s Cobas modular analyzer for the "Roche Blood Safety Solution" launched at Arab Health 2014 (Photo courtesy of Roche Diagnostics).
Image: Arab Health delegates meet with Roche delegates at the 2014 Arab Health Exhibition and Congress (Photo courtesy of Roche Diagnostics).
Image: Arab Health delegates meet with Roche delegates at the 2014 Arab Health Exhibition and Congress (Photo courtesy of Roche Diagnostics).
A first in the Middle East, a comprehensive blood-screening portfolio from a single source provides advanced serology screening and nucleic acid testing (NAT) technologies at blood centers, enhancing health standards in the region.

Roche Diagnostics Middle East (RDME), of the Roche company (Basel, Switzerland), has now launched the "Roche Blood Safety Solution" (RBSS) at the 2014 Arab Health Congress (Dubai, UAE), the largest healthcare exhibition and education congress in the Middle East. The RBSS portfolio, the first of its kind in the region, delivers reliability and workflow efficiency for Middle East blood centers, reaffirming RDME’s dedication to providing first class diagnostics in the region.

RBSS now enables patients and communities in the region to benefit from a dedicated, safe and efficient, reliable blood supply. The blood supply is made safe by a reduction in manual steps as well as excellent state-of-the-art assay sensitivity and genotype coverage. With technologies such as electrochemiluminescence (ECL) and polymerase chain reaction (PCR), laboratories benefit from high specificity and NAT real-time-target-discrimination. The systems provide the highest reliability available, excellent traceability and cross-contamination control, and less downtime.

Roche is the first IVD company to have a management center and a logistics hub in the Middle East, enabling RDME to develop from being a regional supplier into becoming a local IVD partner for its customers. The RBSS portfolio safeguards patients through leading technologies with dedication to, and investment in, the safety of the world’s blood supply. “Owing largely to our dedication to safeguard the world’s blood supply through technological innovations and drug development, Roche Diagnostics has become the preferred partner in the Blood Bank Industry,” said Michael Heuer, President of Europe, Middle East, Africa, and Latin America at Roche Diagnostics.

“RBSS benefits from the design, support, and streamlined supply chain that you would associate with [Roche]. We are proud to bring RBSS to the Middle East,” added Moritz Hartmann, General Manager of Roche Diagnostics Middle East. Roche offers service and support for reliability in all its workflow solutions, including the RBSS blood-screening platform, with dependable systems that help blood centers enhance workflow efficiency, minimizing processing time. The RBSS workflow solution is driving the concept of automation and setting new industry standards in diagnostic testing. Molecular testing processes will be brought together in a highly automated solution, without the need for manual transfer steps and with results calculated automatically and sent to the laboratory information system. The ease of operation coupled with ease of training result in staff competent in the use of RBSS systems. Furthermore, support structures in the Middle East help ensure operation of the systems with less downtime.

Related Links:

Roche 
Arab Health Congress


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.